Pharmaceutical industry news
Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.
42,422 stories, page 514 of 708
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry
NCT07005128: A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
Study type: INTERVENTIONAL. Phase: PHASE3.
ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry
NCT05886049: A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
Study type: INTERVENTIONAL. Phase: PHASE1.
ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry
NCT04886180: Evaluation of Oxiris Membrane as a Treatment for Ischemia-reperfusion Syndrome in Cardiogenic Shock Treated With Extracorporeal Life Support (ECMO/ECLS): A Randomized Pilot Study ECMORIX
Study type: INTERVENTIONAL. Phase: NA.
ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry
NCT04640142: Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases
Study type: INTERVENTIONAL. Phase: PHASE3.
ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry
NCT04188145: A Randomized Phase III Study Comparing Maintenance Treatment With Fluoropyrimidine + Bevacizumab Versus Fluoropyrimidine After Induction Chemotherapy for a Metastatic Colorectal Cancer
Study type: INTERVENTIONAL. Phase: PHASE3.
ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry
NCT04169737: Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Study type: INTERVENTIONAL. Phase: PHASE2.
ClinicalTrials.govOriginal source






